2014
DOI: 10.1016/j.oooo.2012.04.022
|View full text |Cite
|
Sign up to set email alerts
|

Tacrolimus on Kimura's disease: a case report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 11 publications
0
5
0
Order By: Relevance
“…The remission of proteinuria is well documented in MCD and mesangioproliferative glomerulonephritis. 31 Balwani et al also demonstrated remission of proteinuria and prevention of relapsing lymphadenopathy with low-dose tacrolimus (0.05 mg/kg/day). 32 Our patient did not achieve remission with oral corticosteroids for 6 weeks, which prompted the use of tacrolimus.…”
Section: Discussionmentioning
confidence: 96%
“…The remission of proteinuria is well documented in MCD and mesangioproliferative glomerulonephritis. 31 Balwani et al also demonstrated remission of proteinuria and prevention of relapsing lymphadenopathy with low-dose tacrolimus (0.05 mg/kg/day). 32 Our patient did not achieve remission with oral corticosteroids for 6 weeks, which prompted the use of tacrolimus.…”
Section: Discussionmentioning
confidence: 96%
“…3 Recently, a study showed the efficacy of tacrolimus on Kimura's disease. 10 The 2 previously reported patients with IgA nephropathy were treated with corticosteroids and showed significant decrease in proteinuria. 7,8 However, in the Vietnamese patient, a full-blown nephrotic syndrome rapidly recurred after steroids were tapered.…”
Section: Discussionmentioning
confidence: 99%
“…The analysis showed that surgical excision alone and radiotherapy alone had higher rates of local recurrence (Relative Risk: 4.722 and 2.718 respectively), compared to a combination of surgical excision and postoperative low dose irradiation. The use of immunosuppressive agents such as azathioprine (49), cyclosporin (49)(50)(51)(52)(53)(54), tacrolimus (55,56), methotrexate (57), mycophenolate mofetil (58,59), leflunomide (60,61), and cyclophosphamide (59,62) have been reported but also with variable outcomes. Cetirizine (63), an anti-allergy, omalizumab (64), an anti-IgE therapy and mepolizumab (65), an anti-interleukin-5 have also been used to treat Kimura disease with favourable outcomes.…”
Section: Discussionmentioning
confidence: 99%